Mathios, D., Park, C., Marcus, W. D., Alter, S., Rhode, P. R., Jeng, E. K., . . . Lim, M. (2015). Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model. Int J Cancer.
Citação norma ChicagoMathios, Dimitrios, Chul-Kee Park, Warren D. Marcus, Sarah Alter, Peter R. Rhode, Emily K. Jeng, Hing C. Wong, Drew M. Pardoll, and Michael Lim. "Therapeutic Administration of IL-15 Superagonist Complex ALT-803 Leads to Long-term Survival and Durable Antitumor Immune Response in a Murine Glioblastoma Model." Int J Cancer 2015.
Citação norma MLAMathios, Dimitrios, et al. "Therapeutic Administration of IL-15 Superagonist Complex ALT-803 Leads to Long-term Survival and Durable Antitumor Immune Response in a Murine Glioblastoma Model." Int J Cancer 2015.